Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06628596 · ClinicalTrials.gov registry record · Phase 1
Acute Effects of Paraxanthine on Energy and Focus
A Phase 1 study, sponsored by Iovate Health Sciences International.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT06628596 is a Phase 1 study that has completed, run by Iovate Health Sciences International. The registered enrollment target is 25 participants.
The verdict
NCT06628596, a Phase 1 study, has completed, sponsored by Iovate Health Sciences International.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study aims to evaluate the effects of paraxanthine (200 mg and 300 mg) on energy, focus, appetite, and cognitive performance in healthy adults. Using a double-blind, placebo-controlled, crossover design, participants will receive paraxanthine or placebo 30 minutes before a meal. Cognition tests and visual Analogue Scale (VAS) ratings for energy, focus, productivity, satiety, and appetite will be collected at multiple time points post-consumption.
Interventions
- DIETARY_SUPPLEMENT Paraxanthine 200mg and 300mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2024-05-07 |
| Est. Completion | 2024-08-14 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06628596
The ClinicalTrials.gov registry entry for NCT06628596 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Iovate Health Sciences International, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Paraxanthine 200mg and 300mg is the first listed.
NCT06628596 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06628596 about?
NCT06628596 is a clinical study titled "Acute Effects of Paraxanthine on Energy and Focus". This study aims to evaluate the effects of paraxanthine (200 mg and 300 mg) on energy, focus, appetite, and cognitive performance in healthy adults. Using a double-blind, placebo-controlled, crossover design, participants will receive paraxanthine or placebo 30 minutes before a meal. Cognition tests...
What is the current status of trial NCT06628596?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2024-05-07. Estimated completion is 2024-08-14.
What interventions are being tested in trial NCT06628596?
The interventions under investigation include: Paraxanthine 200mg and 300mg (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06628596?
This trial is sponsored by Iovate Health Sciences International, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.